Advanced Solid Tumors With an Alteration of the PIK3CA Gene Active Not Recruiting Phase 1 Trials for Fulvestrant (DB00947)

IndicationStatusPhase
DBCOND0049176 (Advanced Solid Tumors With an Alteration of the PIK3CA Gene)Active Not Recruiting1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01219699A Study of BYL719 in Adult Patients With Advanced Solid Malignancies, Whose Tumors Have an Alteration of the PIK3CA GeneTreatment